Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'.

ABSTRACT:

SUBMITTER: Schafer M

PROVIDER: S-EPMC7082542 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'.

Schäfer Michaela M Oeing Christian U CU Rohm Maria M Baysal-Temel Ezgi E Lehmann Lorenz H LH Bauer Ralf R Volz H Christian HC Boutros Michael M Sohn Daniela D Sticht Carsten C Gretz Norbert N Eichelbaum Katrin K Werner Tessa T Hirt Marc N MN Eschenhagen Thomas T Müller-Decker Karin K Strobel Oliver O Hackert Thilo T Krijgsveld Jeroen J Katus Hugo A HA Berriel Diaz Mauricio M Backs Johannes J Herzig Stephan S

Molecular metabolism 20200304

PMID: 32244184

Similar Datasets

Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia.

Project description:ObjectivesCancer cachexia affects the majority of tumor patients and significantly contributes to high mortality rates in these subjects. Despite its clinical importance, the identity of tumor-borne signals and their impact on specific peripheral organ systems, particularly the heart, remain mostly unknown.Methods and resultsBy combining differential colon cancer cell secretome profiling with large-scale cardiomyocyte phenotyping, we identified a signature panel of seven "cachexokines", including Bridging integrator 1, Syntaxin 7, Multiple inositol-polyphosphate phosphatase 1, Glucosidase alpha acid, Chemokine ligand 2, Adamts like 4, and Ataxin-10, which were both sufficient and necessary to trigger cardiac atrophy and aberrant fatty acid metabolism in cardiomyocytes. As a prototypical example, engineered secretion of Ataxin-10 from non-cachexia-inducing cells was sufficient to induce cachexia phenotypes in cardiomyocytes, correlating with elevated Ataxin-10 serum levels in murine and human cancer cachexia models.ConclusionsAs Ataxin-10 serum levels were also found to be elevated in human cachectic cancer patients, the identification of Ataxin-10 as part of a cachexokine cocktail now provides a rational approach towards personalized predictive, diagnostic and therapeutic measures in cancer cachexia.

| S-EPMC4735665 | biostudies-literature

Cs(10)Ta(29.27)o(78).

Project description:Single crystals of caesium tantalate(V), Cs(10)Ta(29.27)O(78), were obtained as a serendipitous product in a welded tantalum ampoule by a blank reaction of CsBr and bis-muth subnitrate [Bi(5)O(OH)(9)(NO(3))(4)] with the container material. The crystal structure of the title compound is made up of a three-dimensional framework constituted by two types of layers, viz. (Ta(6)O(15))(n) and (Ta(3)O(9))(n), parallel to (001), which are linked together by TaO(6) octa-hedra (3m. symmetry) along [001]. This framework has cavities where three independent Cs(+) ions (3m. and m2 symmetry, respectively) are located. The compound reveals a Ta deficiency at one trigonal prismatic coordinated site (m2 symmetry). The composition of the title compound was verified by energy-dispersive X-ray analysis of single crystals.

| S-EPMC2968405 | biostudies-literature

Aurora B-dependent phosphorylation of Ataxin-10 promotes the interaction between Ataxin-10 and Plk1 in cytokinesis.

Project description:Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant neurologic disorder caused by ATTCT expansion in the ATXN10 gene. Previous investigations have identified that depletion of Ataxin-10, the gene product, leads to cellular apoptosis and cytokinesis failure. Herein we identify the mitotic kinase Aurora B as an Ataxin-10 interacting partner. Aurora B interacts with and phosphorylates Ataxin-10 at S12, as evidenced by in vitro kinase and mass spectrometry analysis. Both endogenous and S12-phosphorylated Ataxin-10 localizes to the midbody during cytokinesis, and cytokinetic defects induced by inhibition of ATXN10 expression is not rescued by the S12A mutant. Inhibition of Aurora B or expression of the S12A mutant renders reduced interaction between Ataxin-10 and polo-like kinase 1 (Plk1), a kinase previously identified to regulate Ataxin-10 in cytokinesis. Taken together, we propose a model that Aurora B phosphorylates Ataxin-10 at S12 to promote the interaction between Ataxin-10 and Plk1 in cytokinesis. These findings identify an Aurora B-dependent mechanism that implicates Ataxin-10 in cytokinesis.

| S-EPMC4322367 | biostudies-literature

Abstracts of the 10th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Rome, Italy, 8‐10 December 2017 (Part 2)